Document is current

Any future updates will be listed below

Kein Überlebensvorteil mit neoadjuvantem FOLFIRINOX

Crossref DOI link: https://doi.org/10.1007/s15004-024-0700-4

Published Online: 2024-09-12

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark